Edition:
United States

People: Celgene Corp (CELG.O)

CELG.O on Nasdaq

104.91USD
12:35pm EDT
Change (% chg)

$2.14 (+2.08%)
Prev Close
$102.77
Open
$103.42
Day's High
$105.24
Day's Low
$102.70
Volume
2,069,337
Avg. Vol
4,309,781
52-wk High
$128.39
52-wk Low
$93.05

Loughlin, James 

Mr. James J. Loughlin serves as Independent Director of Celgene Corp. He is Chairman of the Audit Committee since June 2008 and a member of the Compensation Committee since June 2008. Mr. Loughlin served as the National Director of the Pharmaceuticals Practice at KPMG LLP (KPMG), and a five-year term as member of the Board of Directors of KPMG. Additionally, Mr. Loughlin served as Chairman of the Pension and Investment Committee of the KPMG Board from 1995 through 2001. He also served as Partner in charge of Human Resources, Chairman of the Personnel and Professional Development Committee, Secretary and Trustee of the Peat Marwick Foundation and a member of the Pension, Operating and Strategic Planning Committees. Mr. Loughlin serves as a member of the Board of Directors and the Audit Committee of Edge Therapeutics, Inc., a privately-held biopharmaceutical company, and InspireMD, a publicly-traded medical device manufacturer.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Hugin

22,472,900

Jacqualyn Fouse

8,073,500

Mark Alles

7,912,170

Peter Kellogg

5,705,640

Thomas Daniel

7,341,980

Scott Smith

4,783,240
As Of  30 Dec 2015